Research Fellowship

我是一名心脏病学研究科学家，研究生理性(“好”)和病理性(“坏”)心脏生长--心肌肥厚之间的差异。总的来说，心力衰竭的研究和治疗一直集中在识别和抑制病理过程上。相比之下，我的研究是独一无二的，因为它专注于激活衰竭心脏中的生理通路(在运动员心脏中升高)，作为治疗心力衰竭和心房颤动的潜在新策略。

I am a cardiology research scientist investigating the differences between physiological (“good”) and pathological (“bad”) heart growth- cardiac hypertrophy. In general, heart failure research and therapy has concentrated on identifying and inhibiting pathological processes. In contrast, my research is unique because it has focused on activating physiological pathways (elevated in the athlete’s heart) in the failing heart as a potential new strategy for the treatment of heart failure and atrial fibrillation.